Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Albert I. Ko, MD (he/him/his)

Professor
Yale School of Public Health/Oswaldo Cruz Foundation/Brazilian Ministry of Health
New Haven, Connecticut, United States

Dr. Albert Icksang Ko is the Raj and Indra Nooyi Professor of Public Health at the Yale School of Public Health and Collaborating Researcher at the Oswaldo Cruz Foundation, Brazilian Ministry of Health. He served as Chair of the Department of Epidemiology of Microbial Diseases at Yale (2010-2021) after being stationed with the Brazilian Ministry of Health in Salvador, Brazil for 15 years. His research centers on the health problems that have emerged as a consequence of rapid urbanization and social inequity. Dr. Ko coordinates an urban health program in Brazil, which focuses on delineating the role of social marginalization, urban ecology, and climate on infectious disease threats to informal settlements and implementing community-driven interventions in these settings. Dr. Ko and his team have mobilized the research and public health response to multiple epidemics, which include meningitis, leptospirosis, dengue, Zika virus infection and associated birth defects, and the COVID-19 pandemic. He serves as a principal investigator of several NIAID research programs, including a cluster randomized controlled trial in Brazil which is evaluating the effectiveness of Wolbachia-infected Aedes Aegypti in reducing arboviral infection. Dr. Ko devotes a significant part of his efforts to global health training as program director of a Fogarty Global Infectious Disease Training Program (2003-2012) in Brazil and a Global Health LAUNCH Consortium (2012-present), which has trained 199 fellows in 21 LMIC sites in the past 12 years. He is a member of the WHO R&D Blueprint Working Group and Taskforce for Zika Virus and the NASEM Forum of Microbial Threats. During the pandemic, he was the co-chair of Reopen Connecticut Advisory Group which developed the state’s COVID-19 response plan and served as advisor to Governor Lamont, in addition to providing support to the Oswaldo Cruz Foundation for its pandemic response in Brazil.

Disclosure(s): Merck and Company, Inc.: Member, Scientific Advisory Committee, Dengue Vaccine Program (Ongoing); Takeda Vaccines: Grant/Research Support (Ongoing); Valneva Austria GmbH: Grant/Research Support (Ongoing)

Presentation(s):